gs-9256 and Hepatitis-C--Chronic

gs-9256 has been researched along with Hepatitis-C--Chronic* in 1 studies

Trials

1 trial(s) available for gs-9256 and Hepatitis-C--Chronic

Article	Year
Antiviral response and resistance analysis of treatment-naïve HCV infected patients receiving multiple doses of the NS3 protease inhibitor GS-9256. Antiviral research, 2017, Volume: 140 Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance, Viral; Female; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; High-Throughput Nucleotide Sequencing; Humans; Male; Middle Aged; Mutation; Peptides, Cyclic; Phosphinic Acids; Protease Inhibitors; Viral Load; Viral Nonstructural Proteins	2017

Article

Year

Antiviral response and resistance analysis of treatment-naïve HCV infected patients receiving multiple doses of the NS3 protease inhibitor GS-9256.

Antiviral research, 2017, Volume: 140

Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance, Viral; Female; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; High-Throughput Nucleotide Sequencing; Humans; Male; Middle Aged; Mutation; Peptides, Cyclic; Phosphinic Acids; Protease Inhibitors; Viral Load; Viral Nonstructural Proteins

2017